Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

How our clients use DrugPatentWatch

Generated: May 26, 2017

DrugPatentWatch Database Preview

Fexofenadine hydrochloride; pseudoephedrine hydrochloride - Generic Drug Details

« Back to Dashboard

What are the generic sources for fexofenadine hydrochloride; pseudoephedrine hydrochloride and what is the scope of fexofenadine hydrochloride; pseudoephedrine hydrochloride freedom to operate?

Fexofenadine hydrochloride; pseudoephedrine hydrochloride
is the generic ingredient in three branded drugs marketed by Sanofi Aventis Us, Sun Pharma Global, Barr, Dr Reddys Labs Ltd, and Impax Pharms, and is included in seven NDAs. There are five patents protecting this compound. Additional information is available in the individual branded drug profile pages.

Fexofenadine hydrochloride; pseudoephedrine hydrochloride has eighty patent family members in thirty-two countries.

There are twenty-three drug master file entries for fexofenadine hydrochloride; pseudoephedrine hydrochloride. Sixteen suppliers are listed for this compound. There are three tentative approvals for this compound.

Summary for Generic Name: fexofenadine hydrochloride; pseudoephedrine hydrochloride

Tradenames:3
Patents:5
Applicants:5
NDAs:7
Drug Master File Entries: see list23
Suppliers / Packagers: see list16
Clinical Trials: see list1,013
Drug Prices:see low prices
DailyMed Link:fexofenadine hydrochloride; pseudoephedrine hydrochloride at DailyMed

Pharmacology for Ingredient: fexofenadine hydrochloride; pseudoephedrine hydrochloride

Tentative approvals for FEXOFENADINE HYDROCHLORIDE; PSEUDOEPHEDRINE HYDROCHLORIDE

Applicant Application No. Strength Dosage Form
► Subscribe► Subscribe60/120MGTABLET, EXTENDED RELEASE; ORAL
► Subscribe► Subscribe60MG; 120MGTABLET, EXTENDED RELEASE; ORAL
► Subscribe► Subscribe60MG; 120MGTABLET, EXTENDED RELEASE; ORAL
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Sun Pharma Global
FEXOFENADINE HYDROCHLORIDE AND PSEUDOEPHEDRINE HYDROCHLORIDE
fexofenadine hydrochloride; pseudoephedrine hydrochloride
TABLET, EXTENDED RELEASE;ORAL090818-001Jan 29, 2015OTCNoNo► Subscribe► Subscribe
Barr
FEXOFENADINE HYDROCHLORIDE AND PSEUDOEPHEDRINE HYDROCHLORIDE
fexofenadine hydrochloride; pseudoephedrine hydrochloride
TABLET, EXTENDED RELEASE;ORAL076236-001Apr 14, 2005DISCNNoNo► Subscribe► Subscribe
Impax Pharms
FEXOFENADINE HYDROCHLORIDE AND PSEUDOEPHEDRINE HYDROCHLORIDE
fexofenadine hydrochloride; pseudoephedrine hydrochloride
TABLET, EXTENDED RELEASE;ORAL076298-001Nov 12, 2010DISCNNoNo► Subscribe► Subscribe
Sanofi Aventis Us
ALLEGRA-D 24 HOUR ALLERGY AND CONGESTION
fexofenadine hydrochloride; pseudoephedrine hydrochloride
TABLET, EXTENDED RELEASE;ORAL021704-002Jan 24, 2011OTCYesYes6,613,357► SubscribeY ► Subscribe
Dr Reddys Labs Ltd
FEXOFENADINE HYDROCHLORIDE AND PSEUDOEPHEDRINE HYDROCHLORIDE
fexofenadine hydrochloride; pseudoephedrine hydrochloride
TABLET, EXTENDED RELEASE;ORAL079043-002Jun 22, 2011OTCNoNo► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Subscribe for Complete Access

  • Anticipate P&T budget requirements
  • Formulary management
  • Drug patents and clinical trials in dozens of countries

► Plans and Pricing

Expired Orange Book Patents

 Available with subscription

Paragraph IV Activity

 Available with subscription

Patent Maintenance

 Available with subscription

Non-Orange Book Patents

 Available with subscription

International Patents

 Available with subscription

Supplementary Protection Certificates

 Available with subscription

« Back to the Dashboard

For more information try a trial or see the database preview and plans and pricing

How our clients use DrugPatentWatch

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot